← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Oxaliplatin currently has availability issues reported in 6 European registers: Austria, Spain, Greece, Ireland, Italy, Sweden.
Shortage ATC L01XA03 · also listed as: OXALIPLATIN · OXALIPLATINO · data refreshed 5 November 2026
As of 5 November 2026, 6 of the 10 tracked registers list current availability issues for Oxaliplatin, covering 13 affected product presentations. The longest-running open report was filed in Italy on 2025-02-24 and has now been open for about 21 months. Where agencies state a cause, manufacturing problems lead with 5 of the 9 stated-cause reports, followed by commercial decisions or discontinuation with 2. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-11-21. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 4 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Italy reported first (2025-02-24), with Greece following roughly 17 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Greece, Ireland, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Oxaliplatin is coded L01XA03 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Shortage Oxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung (PZN 3787986) + 1 more productsOxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung (PZN 3787992) | 2026-06-19 | 2026-12-31 | Erhöhter Mehrbedarf | register ↗ |
| 🇪🇸 Spain | Shortage OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 10 ml + 1 more productsOXALIPLATINO HIKMA 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 20 ml | 2026-01-07 | 2026-12-30 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇬🇷 Greece | Limited availability OXALIZOR C/S.SOL.IN 5MG/ML BTx1 (VIALx20 ML) | 2026-07-07 | 2026-09-07 | VOCATE ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Καθυστέρηση παράδοσης περιεκτικότητας Alternatives: Εναλλακτικά άλλα σκευάσματα της ίδιας δραστικής, μορφής και | register ↗ |
| 🇮🇪 Ireland | Shortage Oxaliplatin 5 mg / ml Concentrate for Solution for Infusion | 2026-03-17 | — | Manufacturing delay Alternatives: Exact alternative medicine authorised | register ↗ |
| 🇮🇹 Italy | Shortage OXALIPLATINO ACCORD + 6 more productsOXALIPLATINO ACCORD OXALIPLATINO AUROBINDO ITALIA OXALIPLATINO AUROBINDO ITALIA OXALIPLATINO AUROBINDO ITALIA OXALIPLATINO SANDOZ OXALIPLATINO SUN | 2025-02-24 | — | Motivi commerciali Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
| 🇸🇪 Sweden | Shortage Oxaliplatin Fresenius Kabi 5 mg/ml Koncentrat till infusionsvätska, lösning | 2026-02-01 | 2026-12-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Oxaliplatin in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | OXALIPLATINO AUROBINDO ITALIA | Shortage | 2026-10-09 | — | Elevata richiesta/problemi produttivi |
| 🇮🇹 IT | OXALIPLATINO SUN | Shortage | 2026-10-01 | — | Elevata richiesta: distribuzione contingentata |
| 🇮🇹 IT | OXALIPLATINO ACCORD | Shortage | 2026-09-30 | — | Motivi commerciali |
| 🇮🇹 IT | OXALIPLATINO AUROBINDO ITALIA | Shortage | 2026-08-30 | — | Problemi produttivi |
| 🇬🇷 GR | OXALIZOR C/S.SOL.IN 5MG/ML BTx1 (VIALx20 ML) | Limited availability | 2026-07-07 | 2026-09-07 | VOCATE ΦΑΡΜΑΚΕΥΤΙΚΗ Α.Ε. Καθυστέρηση παράδοσης περιεκτικότητ |
| 🇪🇸 ES | OXALIPLATINO HIKMA 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EF | Shortage | 2026-06-29 | 2026-11-21 | Existen otros medicamentos con el mismo principio activo y m |
| 🇦🇹 AT | Oxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer Infusionsl | Shortage | 2026-06-19 | 2026-12-31 | Erhöhter Mehrbedarf |
| 🇦🇹 AT | Oxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer Infusionsl | Resolved | 2026-06-19 | 2026-10-31 | Erhöhter Mehrbedarf |
| 🇮🇪 IE | Oxaliplatin 5 mg / ml Concentrate for Solution for Infusion | Shortage | 2026-03-17 | — | Manufacturing delay |
| 🇮🇹 IT | OXALIPLATINO AUROBINDO ITALIA | Shortage | 2026-03-08 | — | Problemi produttivi |
| 🇸🇪 SE | Oxaliplatin Fresenius Kabi 5 mg/ml Koncentrat till infusionsvätska, lö | Shortage | 2026-02-01 | 2026-12-31 | |
| 🇪🇸 ES | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION E | Shortage | 2026-01-07 | 2026-12-30 | Existen otros medicamentos con el mismo principio activo y m |
| 🇮🇹 IT | OXALIPLATINO SANDOZ | Shortage | 2025-11-24 | — | Cessata commercializzazione definitiva |
| 🇮🇹 IT | OXALIPLATINO ACCORD | Shortage | 2025-02-24 | — | Problemi produttivi: ridotta disponibilità |
Yes. As of 5 November 2026, availability issues are reported in: Austria, Spain, Greece, Ireland, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-11-21 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
12 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Oxaliplatin: BASG (Austria), AEMPS CIMA (Spain), EOF limited-availability list (Greece), HPRA (Ireland), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Oxaliplatin — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/oxaliplatin/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Oxaliplatin availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/oxaliplatin/">Oxaliplatin shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>